Genetic determination of plasma aldosterone levels in essential hypertension

American Journal of Hypertension

Volumn 11, Issue 7, 1998, Pages 856-860

  Pojoga, Luminita ^a   Gautier, Sylvie ^a   Blanc, Hervé ^b   Guyene, Than Tan ^a   Poirier, Odette ^b   Combien, François ^b   Benetos, Athanase ^a,b  

^a INSERM   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

Aldosterone synthase; Aldosterone synthase gene; Arterial stiffness; Genetics; Reninangiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTERY COMPLIANCE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGE FACTORS; ALDOSTERONE; ALDOSTERONE SYNTHASE; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CHI-SQUARE DISTRIBUTION; DIASTOLE; GENE FREQUENCY; GENETIC SCREENING; GENOTYPE; HEART RATE; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; PULSE; RENIN; SODIUM; SYSTOLE;

EID: 0032127080     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00048-X     Document Type: Article

References (29)

1. 1. Dzau VJ, Safar ME: Large conduit arteries in hypertension: role of the renin-angiotensin system. Circulation 1988;77:947-953.
2. 2. Naftilan AJ, Williams R, Burt D, et al: A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension 1989;14:219-224.
3. 3. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-644.
4. 4. Danser AHJ, Schalekamp MADH, Bax WA, et al: Angiotensin-converting enzyme in human heart. Circulation 1995;92:1387-1388.
5. 5. Schunkert H, Hense H-W, Holmer SR, et al: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-1638.
6. 6. Castellano M, Mulesan ML, Rizzoni D, et al: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in general population. The Vobarno study. Circulation 1995;91:2721-2724.
7. 7. Tiret L, Kee F, Poirier O, et al: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341:991-992.
8. 8. Rogg H, Schmid A, de Gasparo M: Identification and characterisation of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun 1990;173:416-422.
9. 9. Bonnardeaux A, Davies E, Jeunemaitre X, et al: Angiotensin II Type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-69.
10. 10. Tiret L, Bonnardeaux A, Poirier O, et al: Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphism on the risk of myocardial infarction. Lancet 1994;344:910-913.
11. 11. Benetos A, Gautier S, Ricard S, et al: Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996; 94:698-703.
12. 12. Benetos A, Topouchian J, Ricard S, et al: Influence of angiotensin II Type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995;26:44-47.
13. 13. Benetos A, Cambien F, Gautier S, et al: Angiotensin II AT1 receptor gene polymorphism influences the efficacy of chronic angiotensin converting enzyme inhibition on blood pressure and arterial stiffness in hypertensives. Hypertension 1996;28:1081-1084.
14. 14. White PC: Molecular biology of adrenocortical hypertension, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management, 2nd Edition. Raven, New York, 1995, pp 2177-2184.
15. 15. Lombes M, Oblin ME, Gasc JM, et al: Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 1992;71:503-510.
16. 16. Takeda Y, Miyamori I, Yoneda T, et al: Production of aldosterone in isolated rat blood vessels. Hypertension 1995;25:170-173.
17. 17. Benetos A, Lacolley P, Safar M: Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Res 1997;17:1152-1156.
18. 18. White PC, Slutsker L: Haplotype analysis of CYP11B2. Endocr Res 1995;21:437-442.
19. 19. White PC, Curnow KM, Pascoe L: Disorders of steroid 11β-hydroxylase isoenzymes. Endocr Rev 1994;15:421-438.
20. 20. Pascoe L, Curnow KM, Slutsker L, et al: Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase deficiency. Proc Natl Acad Sci USA 1992;89:4996-5000.
21. 21. Mitsuuchi Y, Kawamoto T, Rösler A, et al: Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450C18 gene (CYP11B2) in CMOII deficient patients. Biochem Biophys Res Commun 1992;182:974-979.
22. 22. Avolio AP, Deng FQ, Li WQ, et al: Effects on aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71:202-215.
23. 23. Asmar R, Benetos A, London G, et al: Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Pressure 1995;4:48-54.
24. 24. Menard J, Guyene TT, Corvol P, et al: Direct immunometric assay of active renin in human plasma. J Hypertens 1985;3(suppl 3):S275-S278.
25. 25. Simon D, Badouaille G, Pau B, et al: Measurements of active renin by the HG1 anti-human renin monoclonal antibody. Clin Exp Hypertens [A], 1987;A9:1333-1340.
26. 26. Plouin PF, Chatellier G, Guyene TT, et al: Recent progress in the clinical exploration of the renin-angiotensin-aldosterone system. Presse Médicale, 1989;18: 917-921.
27. 27. Saiki RK: Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes. Nature 1986;324:163-166.
28. 28. Fardella CE, Rodriguez H, Montero J, et al: Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab 1996;81: 4347-4251.
29. 29. Kupari M, Hautanen A, Lankinen L, et al: Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998;97:569-575.